Hoth Therapeutics Files Prospectus Supplement for Stock Offering
Ticker: HOTH · Form: 424B5 · Filed: 2026-04-02T13:39:13-04:00
Sentiment: neutral
Topics: prospectus-supplement, securities-offering, capital-raise
Related Tickers: HOTH
TL;DR
HOTH filing 424B5: They're selling stock, likely to raise cash for drug development.
AI Summary
Hoth Therapeutics, Inc. filed a prospectus supplement (424B5) on April 2, 2026, detailing the terms of a securities offering. The filing indicates the company is offering shares of its common stock, potentially raising capital for its operations and development programs.
Why It Matters
This filing signals Hoth Therapeutics' intent to raise capital through a stock sale, which could fund its ongoing research and development efforts in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — Prospectus supplements often indicate a company is seeking to raise capital, which can dilute existing shareholders or signal financial needs.
Key Numbers
- 424B5 — Form Type (Indicates a prospectus supplement filing)
- 0001213900-26-039103 — SEC Accession Number (Unique identifier for this specific filing)
Key Players & Entities
- Hoth Therapeutics, Inc. (company) — Filer of the 424B5 form
- 0001711786 (company) — CIK number for Hoth Therapeutics, Inc.
- 2026-04-02 (date) — Filing date of the 424B5 form
- 333-291566 (dollar_amount) — File number associated with the Act 33 filing
FAQ
What is the purpose of this 424B5 filing?
The purpose of this 424B5 filing is to supplement a previously filed registration statement and provide details about an offering of Hoth Therapeutics, Inc.'s securities.
When was this prospectus supplement filed?
This prospectus supplement was filed on April 2, 2026.
What type of securities is Hoth Therapeutics, Inc. offering?
The filing is a prospectus supplement for an offering of common stock, though specific details on the number of shares and price are typically found within the prospectus itself.
What is the CIK number for Hoth Therapeutics, Inc.?
The CIK number for Hoth Therapeutics, Inc. is 0001711786.
What is the business address listed for Hoth Therapeutics, Inc.?
The business address listed is 1177 AVENUE OF THE AMERICAS 5TH FLOOR SUITE 5066 NEW YORK NY 10036.
From the Filing
EDGAR Filing Documents for 0001213900-26-039103 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 424B5 - Prospectus [Rule 424(b)(5)]: SEC Accession No. 0001213900-26-039103 Filing Date 2026-04-02 Accepted 2026-04-02 13:39:13 Documents 3 Document Format Files Seq Description Document Type Size 1 PROSPECTUS SUPPLEMENT ea0284778-424b5_hoth.htm 424B5 438169 2 GRAPHIC ea028477802_img1.jpg GRAPHIC 3461 3 GRAPHIC ea028477802_img2.jpg GRAPHIC 9004 Complete submission text file 0001213900-26-039103.txt 456713 Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR SUITE 5066 NEW YORK NY 10036 Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR SUITE 5066 NEW YORK NY 10036 (646)756-2997 Hoth Therapeutics, Inc. (Filer) CIK : 0001711786 (see all company filings) EIN. : 821553794 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 424B5 | Act: 33 | File No.: 333-291566 | Film No.: 26832026 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)